Clinical trials · Houston, TX
Gastroesophageal Junction Adenocarcinoma clinical trials in Houston
We’re tracking 27 recruiting gastroesophageal junction adenocarcinoma studies with a site in or near Houston — including Phase 1/Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Houston
- NCT05205343Recruiting
Compare minimally invasive and full stomach surgery for upper cancer
This study compares two minimally invasive ways to operate on the stomach area for cancers near the stomach and esophagus (GEJ). It looks at whether one surgical approach is better for long-term outcomes when the goal is cure.
Houston, TexasAges 18 years+ - NCT05086692RecruitingPhase 1/Phase 2
Beta-only IL-2 therapy for advanced solid tumors
This Phase 1/2 study tests a beta-only version of IL-2, an immune-stimulating treatment, to shrink or control advanced or metastatic solid tumors. It’s mainly designed to check safety and to see if it can help patients by improving tumor response.
Houston, TexasAges 18 years+ - NCT06764875RecruitingPhase 3
New drug combo for HER2-positive stomach cancer
This trial tests a new immunotherapy called rilvegostomig combined with standard chemotherapy and a targeted therapy (trastuzumab deruxtecan) for people with advanced HER2-positive stomach or gastroesophageal junction cancer that has not been treated before.
Webster, TexasAges 18 years+
Hear when a new Gastroesophageal Junction Adenocarcinoma trial opens near Houston, TX
We’ll email you when one opens near Houston, TX — at most once a week, no account needed, unsubscribe anytime.
Gastroesophageal Junction Adenocarcinoma trials in other cities
Where these studies are running near Houston
Institutions with a site for the recruiting gastroesophageal junction adenocarcinoma studies listed above.
- The University of Texas MD Anderson Cancer Center · 2 studies
- Research Site
What taking part in a gastroesophageal junction adenocarcinoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting gastroesophageal junction adenocarcinoma studies in Texas.
Common questions
- Are there gastroesophageal junction adenocarcinoma clinical trials near Houston?
- Yes. We're currently tracking 27 recruiting gastroesophageal junction adenocarcinoma studies with a site near Houston, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a gastroesophageal junction adenocarcinoma study near Houston?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Houston to take part?
- Not necessarily. These studies have a site near Houston, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a gastroesophageal junction adenocarcinoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New gastroesophageal junction adenocarcinoma studies open near Houston regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.